UBcare. Co. Ltd (032620) - Cash Flow Conversion Efficiency
Based on the latest financial reports, UBcare. Co. Ltd (032620) has a cash flow conversion efficiency ratio of 0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩184.89 Million ≈ $125.29K USD) by net assets (₩159.99 Billion ≈ $108.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 032620 net asset quality score to measure how much of total assets are equity-financed.
UBcare. Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how UBcare. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of UBcare. Co. Ltd to evaluate the quality of earnings relative to operating cash generation.
UBcare. Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of UBcare. Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Amica S.A.
WAR:AMC
|
0.059x |
|
Emeren Group Ltd
NYSE:SOL
|
0.106x |
|
D O Green Technologies Bhd
KLSE:7204
|
0.022x |
|
Tainergy Tech Co Ltd
TW:4934
|
-0.035x |
|
Avaco Co. Ltd
KQ:083930
|
0.014x |
|
Rafael Holdings, Inc.
NYSE:RFL
|
-0.090x |
|
Kino Indonesia Tbk PT
JK:KINO
|
0.101x |
|
Bank Victoria International
JK:BVIC
|
0.016x |
Annual Cash Flow Conversion Efficiency for UBcare. Co. Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of UBcare. Co. Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is UBcare. Co. Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩158.89 Billion ≈ $107.68 Million |
₩16.63 Billion ≈ $11.27 Million |
0.105x | +342.05% |
| 2024-12-31 | ₩99.22 Billion ≈ $67.24 Million |
₩2.35 Billion ≈ $1.59 Million |
0.024x | +7.93% |
| 2023-12-31 | ₩113.54 Billion ≈ $76.94 Million |
₩2.49 Billion ≈ $1.69 Million |
0.022x | -39.77% |
| 2022-12-31 | ₩116.70 Billion ≈ $79.09 Million |
₩4.25 Billion ≈ $2.88 Million |
0.036x | -45.93% |
| 2021-12-31 | ₩117.89 Billion ≈ $79.89 Million |
₩7.94 Billion ≈ $5.38 Million |
0.067x | -39.01% |
| 2020-12-31 | ₩106.52 Billion ≈ $72.19 Million |
₩11.76 Billion ≈ $7.97 Million |
0.110x | -3.89% |
| 2019-12-31 | ₩102.57 Billion ≈ $69.51 Million |
₩11.79 Billion ≈ $7.99 Million |
0.115x | +39.13% |
| 2018-12-31 | ₩101.66 Billion ≈ $68.90 Million |
₩8.40 Billion ≈ $5.69 Million |
0.083x | -58.86% |
| 2017-12-31 | ₩46.55 Billion ≈ $31.55 Million |
₩9.35 Billion ≈ $6.33 Million |
0.201x | +198.71% |
| 2016-12-31 | ₩46.56 Billion ≈ $31.55 Million |
₩3.13 Billion ≈ $2.12 Million |
0.067x | -60.94% |
| 2015-12-31 | ₩45.31 Billion ≈ $30.70 Million |
₩7.80 Billion ≈ $5.28 Million |
0.172x | +30.76% |
| 2014-12-31 | ₩39.49 Billion ≈ $26.76 Million |
₩5.20 Billion ≈ $3.52 Million |
0.132x | +4.66% |
| 2011-12-31 | ₩47.23 Billion ≈ $32.01 Million |
₩5.94 Billion ≈ $4.02 Million |
0.126x | -- |
About UBcare. Co. Ltd
UBcare. Co., Ltd. provides health care solutions in South Korea and internationally. The company offers medical IT services, such as Ysarang, an EMR system for hospital/clinic use; and U Pharm, an integrated management control system for pharmacies, hospitals, clinics, and pharmacy environments; and Big Ysarang, an EMR system for small and medium-sized hospitals, as well as customer management an… Read more